BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)
September 25, 2013 at 12:52 PM EDT
Among leading biotech and emerging pharmaceutical companies, short sellers moved on BioMarin Pharmaceutical (NASDAQ: BMRN ), Celgene (NASDAQ: CELG ) and Regeneron Pharmaceuticals (NASDAQ: REGN ) the most between the August 30 and September 13 settlement dates. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ:
